Cariprazine
Category: AntipsychoticCariprazine, sold under the brand names Vraylar in the United States and Reagila in the European Union, is an atypical antipsychotic which is used in the treatment of schizophrenia, bipolar mania,[4] and bipolar depression.[5] It acts primarily as a D3 receptor and D2 receptor partial agonist, with high selectivity for the D3 receptor.[6] Positive Phase III study results were published for schizophrenia and mania in early 2012, and for bipolar d... [wikipedia]